Description

Carbamic Acid, [2-Butyl-3-[(3-Chlorophenyl)Methyl]-7-Methyl-3H-Imidazo[4,5-B]Pyridin-6-Yl]-, 1,1-Dimethylethyl Ester (9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of potential drug candidates, particularly those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize the biological activity and pharmacokinetic properties of new chemical entities.
• API Development: Serves as a critical precursor in the multi-step synthesis of complex Active Pharmaceutical Ingredients (APIs) for preclinical and clinical studies.
• Biochemical Research: Employed as a tool compound in biochemical assays to study protein-ligand interactions and cellular mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	Carbamic Acid, [2-Butyl-3-[(3-Chlorophenyl)Methyl]-7-Methyl-3H-Imidazo[4,5-B]Pyridin-6-Yl]-, 1,1-Dimethylethyl Ester (9Ci)
CAS No.	603082-32-2
Molecular Formula	C24H29ClN4O2
Molecular Weight	440.97 g/mol
Synonyms	tert-Butyl N-[2-butyl-3-[(3-chlorophenyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-6-yl]carbamate; 603082-32-2; Carbamic acid, N-[2-butyl-3-[(3-chlorophenyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-6-yl]-, 1,1-dimethylethyl ester; tert-Butyl (2-butyl-3-((3-chlorobenzyl))-7-methyl-3H-imidazo[4,5-b]pyridin-6-yl)carbamate
EINECS	Contact for details

Quality Control

Our Carbamic Acid, [2-Butyl-3-[(3-Chlorophenyl)Methyl]-7-Methyl-3H-Imidazo[4,5-B]Pyridin-6-Yl]-, 1,1-Dimethylethyl Ester (9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.